Court Guts 340B Program
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a "patient" of a 340B program covered entity eligible to receive a 340B drug.
Stay updated with breaking news from Eligible Patient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a "patient" of a 340B program covered entity eligible to receive a 340B drug.
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a patient of a 340B program covered entity eligible to receive a 340B drug. In Genesis...
On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a “patient” of a 340B program covered entity eligible to receive a 340B drug....
Last week, OIG posted Advisory Opinion No. 22-06 regarding a biopharmaceutical company’s (BioPharm Co.) arrangement to provide free genetic testing and genetic counseling services to...
Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Patent Foramen Ovale (PFO) Closure Devices - Market Insights, Competitive Landscape and Market Forecast -...